Pancreatic Cancer Research

ResearcherVan Andel InstituteActive in the last 2 years

Brian B. Haab

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0002-3471-1535; OpenAlex author ID A5046744833. Sources: OpenAlex.

Their work

Papers
12 (first author 0, last author 8)
Trials
0
Grants
0
Labs led
1
Collaborators
57
Papers, trials and grants by year

2013: 1 paper · 2014: 1 paper · 2015: 1 paper · 2016: none · 2017: 1 paper · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: 2 papers · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper

Papers 12

  1. The circadian gene Dec2 promotes pancreatic cancer progression and dormancy through immune evasion. Co-author DOI 10.1016/j.devcel.2026.04.001↗
  2. Multiplexed glycan immunofluorescence identification of pancreatic cancer cell subpopulations in both tumor and blood samples. Last author DOI 10.1126/sciadv.adt0029↗
  3. A rigorous multi-laboratory study of known PDAC biomarkers identifies increased sensitivity and specificity over CA19-9 alone. Co-author DOI 10.1016/j.canlet.2024.217245↗
  4. Heterogeneity of glycan biomarker clusters as an indicator of recurrence in pancreatic cancer. Last author DOI 10.3389/fonc.2023.1135405↗
  5. Imaging Mass Spectrometry and Lectin Analysis of N-Linked Glycans in Carbohydrate Antigen-Defined Pancreatic Cancer Tissues. Co-author DOI 10.1074/mcp.ra120.002256↗
  6. Detection of Chemotherapy-resistant Pancreatic Cancer Using a Glycan Biomarker, sTRA. Last author DOI 10.1158/1078-0432.ccr-20-2475↗
  7. Biomarkers and Strategy to Detect Preinvasive and Early Pancreatic Cancer: State of the Field and the Impact of the EDRN. Last author DOI 10.1158/1055-9965.epi-20-0161↗
  8. The sTRA Plasma Biomarker: Blinded Validation of Improved Accuracy Over CA19-9 in Pancreatic Cancer Diagnosis. Last author DOI 10.1158/1078-0432.ccr-18-3310↗
  9. The CA19-9 and Sialyl-TRA Antigens Define Separate Subpopulations of Pancreatic Cancer Cells. Last author DOI 10.1038/s41598-017-04164-z↗
  10. Definitive Characterization of CA 19-9 in Resectable Pancreatic Cancer Using a Reference Set of Serum and Plasma Specimens. Co-author DOI 10.1371/journal.pone.0139049↗
  11. Mesenchymal-like pancreatic cancer cells harbor specific genomic alterations more frequently than their epithelial-like counterparts. Last author DOI 10.1016/j.molonc.2014.04.007↗
  12. Prediction of glycan motifs using quantitative analysis of multi-lectin binding: Motifs on MUC1 produced by cultured pancreatic cancer cells. Last author DOI 10.1002/prca.201300069↗

Closest collaborators

The 25 strongest of 57 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Randall E. Brand · 7 shared papers, 2015–2025 · strength 0.76
  2. Ying Huang · 7 shared papers, 2015–2025 · strength 0.76
  3. ChongFeng Gao · 4 shared papers, 2019–2025 · strength 0.59
  4. Aatur Dilip Singhi · 5 shared papers, 2017–2025 · strength 0.56
  5. Ben Staal · 4 shared papers, 2019–2025 · strength 0.55
  6. Peter J. Allen · 3 shared papers, 2021–2025 · strength 0.51
  7. Luke Wisniewski · 3 shared papers, 2021–2023 · strength 0.43
  8. Chanjuan Shi · 2 shared papers, 2023–2025 · strength 0.40
  9. Richard R. Drake · 4 shared papers, 2017–2021 · strength 0.37
  10. Anirban Maitra · 3 shared papers, 2019–2024 · strength 0.35
  11. Johannes Francois Fahrmann · 2 shared papers, 2020–2024 · strength 0.27
  12. Samir Hanash · 2 shared papers, 2020–2024 · strength 0.27
  13. Surinder K. Batra · 2 shared papers, 2020–2024 · strength 0.27
  14. Daniel Barnett · 3 shared papers, 2017–2021 · strength 0.25
  15. Michael Anthony Hollingsworth · 2 shared papers, 2015–2026 · strength 0.24
  16. Lan Wang · 1 shared paper, 2026 · strength 0.20
  17. Paula M. Vertino · 1 shared paper, 2026 · strength 0.20
  18. Anna Bianchi · 1 shared paper, 2026 · strength 0.20
  19. Crissy Dudgeon · 1 shared paper, 2026 · strength 0.20
  20. Jean L. Grem · 1 shared paper, 2026 · strength 0.20
  21. Subhajyoti De · 1 shared paper, 2026 · strength 0.20
  22. Brian James Altman · 1 shared paper, 2026 · strength 0.20
  23. Anthony Casabianca · 1 shared paper, 2026 · strength 0.20
  24. Paul M. Grandgenett · 1 shared paper, 2026 · strength 0.20
  25. Jashodeep Datta · 1 shared paper, 2026 · strength 0.20

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.